Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886163-19-000054
Filing Date
2019-03-15
Accepted
2019-03-15 13:59:23
Documents
1
Period of Report
2019-03-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4872
  Complete submission text file 0000886163-19-000054.txt   6267
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address
Aryeh Jason (Reporting) CIK: 0001376960 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 19684493